Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Israel Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20102
20134
20142
20153
20162
20174
20183
20191
20201
20213
20221
20231
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting9
Recruiting5
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Merck Sharp & Dohme LLC6
Tesaro, Inc.4
pharmaand GmbH3
AbbVie2
Hoffmann-La Roche2
Pfizer2
ARCAGY/ GINECO GROUP1
Amgen1
Corcept Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms35
Fallopian Tube Neoplasms14
Carcinoma, Ovarian Epithelial7
Peritoneal Neoplasms4
Breast Neoplasms2
Neoplasms2
Endometrial Neoplasms1
Genital Neoplasms, Male1
Pathologic Complete Response1
Prostatic Neoplasms1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.